$11.99
Today
as of Sep 4, 16:53 ET
Last 30 days
Recent Press Releases & News
Q32 Bio to Participate in Upcoming September Investor Conferences
Wall Street Analysts See an 182.18% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High?
Q32 Bio: Q2 Earnings Snapshot
Overview
52-week range
$1.67
$24
47% of range
Avg surprise (last 2)
+13.9%
Avg reaction (last 2)
+0.0%
50% positive
Latest IV / EM
111%
EM ±17.3% · $13 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.44 | — | — | — | — | financials |
| Tue May 5, 2026 | Mar/2026 | $-0.54 | $-0.52 | -3.9% | +40.0% | +2.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.60 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $-0.78 | $-1.14 | +31.6% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.90 | — | — | — | -1.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1.46 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.42 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-6.33 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-40.52 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-16.69 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-19.84 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $0 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-9M | $-8M | — | $-8M | $-9M | $-12M | — | $-19M |
| Net income | $-9M | $-8M | — | $-7M | $-9M | $-11M | — | $-18M |
| EPS (diluted) | $-0.44 | $-0.54 | — | $-0.60 | $-0.78 | $-0.90 | — | $-1.46 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $106M | $51M | $48M | $49M | $55M | $65M | $78M | $89M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $110M | $57M | $55M | $51M | $58M | $69M | $82M | $94M |
| Total assets | $116M | $64M | $62M | $58M | $66M | $79M | $92M | $105M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $10M | $17M | $20M | $76M | $78M | $83M | $87M | $86M |
| Total equity | $106M | $46M | $42M | $-18M | $-12M | $-4M | $6M | $18M |